SIBYLS Beamline

Brought to you by IDAT, SBDR, ALS-ENABLE, and the DOE

Recent Highlights

SEC-SAXS highlighted in Baker paper

In this Baker paper, published in Nature Communications in November 2024, the authors describe the design of pseudosymmetric protein hetero-oligomers. These proteins are versatile building blocks for creating functional materials[…]

Read more

Nobel Prize in Chemistry awarded to longtime SIBYLS user David Baker

David Baker, one of SIBYLS longest and most committed users, was awarded the Nobel Prize for Chemistry for his work in protein design. SAXS data collected from around 3,000 samples[…]

Read more

2024 BioSAXS Workshop

With talks from four fantastic outside speakers, Dr. John Hackett from Florida International University, Dr. David Buckley from Dr. John Tanner’s lab at the University of Missouri, Dr. Alex Kehl[…]

Read more

Time-Resolved SAXS Screen of Small-Molecule Drug Candidates

SIBYLS made the news for work on time-resolved, high-throughput, small-angle x-ray scattering (SAXS) at the Advanced Light Source (ALS) improving the screening of small-molecule drug candidates, and providing insight into[…]

Read more